Caracemide T14864
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Caracemide is a novel anticancer agent derived from a hydroxamic acid with severe central nervous system (CNS) toxicity. It inhibits the enzyme ribonucleotide reductase of Escherichia coli.
CAS nr:
81424-67-1
Purity:
98%
Molecular Weight:
189,17
SMILES:
CC(N(OC(NC)=O)C(NC)=O)=O
Formula:
C6H11N3O4
Pathway:
Others
Target:
Others
